Words of Wisdom:

"Ellie ist die uber sex and yew want her ^_^" - Lalatan

Global Proteomics Market : Company Profiles and Forecast 2015 - 2021

  • Date Submitted: 12/03/2015 01:18 AM
  • Flesch-Kincaid Score: 31.5 
  • Words: 713
  • Essay Grade: no grades
  • Report this Essay
Dec., 03, 2015, Mumbai, India: Market Reports on China presents the report, on “Global Proteomics Market : Company Profiles and Forecast 2015 - 2021”. Major opportunities for the market lie in the Asian markets where contract research organizations are on a rise.

Proteomics market is expected to grow impressively with approximate compounded annual growth rate of 20% for the forecasted period of 2015-2021. "http://www.marketreportsonchina.com/life-sciences-market-research-reports-18406/global-proteomics-united-states-canada-india-china-japan-united-kingdom.html" The proteomics market is segmented on the basis of proteomics instrumentation technology such as protein micro array (biochips, micro array instruments), spectroscopy (Mass and NMR), X-ray crystallography, chromatography, electrophoresis, proteomics reagents, proteomics services (analytical lab services, protein identification, extraction, sequencing, data analysis, maintaining bioinformatics data bases). The market is driven by growing need of personalized medicines, new discoveries in the field of genomics, rise in funds for proteomics based research, growing research and development expenditure, advancement in technologies, new techniques, high output, high resolutions achiness and instruments have been developed, availability of private funds and rise in the Asian markets like China and Japan. . The top 10 companies own 40 to 50 percent of the market. Proteomic instrumentation market is dominated by proteomic microarray, accounting for around 50% of the revenue followed by spectroscopy techniques. Proteomic reagents market is dominated by immunoassays.

The market is restrained by various factors such as: success ratio of the researches is not very high, limitations of personalized medicines and lengthy regulatory approval process, reduction in funds by the US government, which owes 40% of this market, highly expensive medicines, which are 1000 fold costlier than the normal medicines present in the...

Comments

Express your owns thoughts and ideas on this essay by writing a grade and/or critique.

  1. No comments